Loading...
NPI 1962481820 · Dallas, TX · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Propath Services, LLC is a clinical medical laboratory provider located in Dallas, Texas. This profile covers 153 Medicare and 116 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Propath Services, LLC |
| Address | 1355 River Bend Dr |
| City | Dallas |
| State | TX |
| ZIP | 75247 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | January 10, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $16.8M |
| Medicare | $6.9M |
This provider’s payer mix is dominated by Medicaid by dollar scale: lifetime Medicaid revenue is $16.8M versus Medicare $6.9M, so the organization is not single‑payer and derives substantially more revenue from Medicaid than from Medicare. Both payers are material to operations, but Medicaid is the larger revenue source on file.
Medicare revenue is highly concentrated in a small set of pathology codes: the precomputed top three Medicare codes account for 74.7% of the provider’s total Medicare revenue. Those top Medicare drivers are 88305 ($3.7M, 60.2%), 88341 ($513.2K, 8.3%), and 88342 ($386.4K, 6.2%), indicating surgical pathology and associated immunostain interpretation generate most Medicare dollars.
Medicaid revenue shows a different mix with somewhat less concentration: the precomputed top three Medicaid codes account for 39.3% of total Medicaid revenue. The leading Medicaid codes are 88305 ($2.7M, 17.6%), 87801 ($1.8M, 11.8%), and 87491 ($1.6M, 10.0%), reflecting a blend of surgical pathology and very high-volume nucleic acid amplification testing for infectious agents in the Medicaid population.
The overall code mix signals a high-volume clinical medical laboratory with a strong anatomic pathology footprint and extensive infectious-disease/molecular testing. Heavy Medicare billing for surgical pathology and many immunohistochemistry/ISH codes (88305, 88341, 88342, 88350, 88360) combined with large Medicaid volumes for NAATs and screening tests (87801, 87491, 87591, 87624, U0003) is consistent with a centralized reference lab that performs both diagnostic pathology and high-throughput infectious disease assays.
This provider is a dominant outlier on national Medicare metrics for key pathology codes: 88305 ranks #8 of 14580 providers nationally (100th percentile; extreme outlier), 88341 ranks #13 of 10274 (100th percentile; extreme outlier), and 88342 ranks #20 of 11370 (100th percentile; extreme outlier). Those ranks indicate volumes for these codes far exceed typical national peers and position the lab as a major national supplier of these services.
State-level competitive standing in Texas is similarly pronounced on core codes: on Medicaid, 88305 ranks #2 of 301 providers in-state (100th percentile; extreme outlier) and 87801 ranks #3 of 109 (98th percentile; notably above typical state volume). The provider therefore functions as one of the top in-state laboratories for surgical pathology and high-volume NAAT infectious-agent testing.
Several individual codes demonstrate exceptionally large claim volumes that underscore operational scale: Medicare 88305 shows 74.4K claims and Medicaid 88305 shows 52.6K claims, while Medicaid 87801 reports 51K claims and Medicaid 87491 reports 91.4K claims. These multi‑tens‑of‑thousands claim volumes across both payers are consistent with high-throughput processing capacity rather than a small community lab footprint.
The NPI tenure (enumerated 2006-01-10, ~20 years ago) indicates an established operation with sustained presence; the product mix also includes higher‑complexity services such as genomic panels and advanced cytometry (e.g., Medicare 81450 $69.1K and 81455 $37.2K, plus flow cytometry codes), suggesting the lab supports some advanced diagnostic workflows in addition to large-volume routine and infectious disease testing.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
153 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 74,440 | $50 | $3.7M |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 9,870 | $50 | $513.2K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 5,940 | $70 | $386.4K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 1,830 | $80 | $152.2K |
| 88350 | The analyst performs an immunofluorescent study using a single antibody stain procedure to detect autoimmune disease or an infectious organism in a tissue or cellular sample. Code +88350 describes… | 1,890 | $80 | $149.5K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 4,110 | $30 | $139.8K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under… | 3,970 | $30 | $103.3K |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 380 | $270 | $101.8K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 3,250 | $30 | $100.8K |
| 88360 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist, evaluates the… | 1,470 | $60 | $88.4K |
Showing 1–10 of 153
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 153 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
153 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87798 | 266 | 300 | 790 | $30 | $265.1K |
| 81450 | 2 | 10 | 30 | $700 | $140K |
| 88120 | 7 | 20 | 70 | $420 | $119.2K |
| 81279 | 18 | 20 | 270 | $180 | $86.8K |
| 87801 | 46 | 120 | 170 | $70 | $86.5K |
| 87481 | 48 | 270 | 150 | $30 | $68.8K |
| U0003 | 53 | 60 | 100 | $70 | $64.7K |
| 81455 | 4 | 10 | 30 | $2,790 | $64.2K |
| 86480 | 22 | 30 | 60 | $60 | $61.4K |
| 88305 | 3 | 1,120 | 400 | $40 | $51.6K |
Showing 1–10 of 153
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
116 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 52,620 | $50 | $2.7M |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 51,000 | $40 | $1.8M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 91,420 | $20 | $1.6M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 91,000 | $20 | $1.5M |
| 88175 | The lab analyst performs the technical lab test to analyze a cervical or vaginal cytopathology specimen that a clinician collected in preservative fluid. The test uses automated thin layer… | 87,640 | $20 | $1.3M |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 70,100 | $20 | $1.1M |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 53,330 | $20 | $799.9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 9,930 | $70 | $645.1K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 46,380 | $10 | $510.2K |
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 11,570 | $40 | $486.1K |
Showing 1–10 of 116
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
116 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 18 | 20 | 180 | $200 | $923K |
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 5 | 20 | 250 | $40 | $821.3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 33 | 340 | 400 | $50 | $553.5K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 21 | 150 | 170 | $30 | $302.9K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 18 | 240 | 420 | $30 | $296.8K |
| 88175 | The lab analyst performs the technical lab test to analyze a cervical or vaginal cytopathology specimen that a clinician collected in preservative fluid. The test uses automated thin layer… | 5 | 70 | 800 | $20 | $268.3K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 8 | 290 | 410 | $20 | $225K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 8 | 300 | 410 | $20 | $223.4K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 7 | 150 | 320 | $20 | $184K |
| 81329 | The lab analyst performs the technical lab test to detect deletions in the survival of motor neuron 1 (SMN1), telomeric, gene and may also analyze the survival of motor neuron 2 (SMN2), centromeric,… | 12 | 20 | 70 | $40 | $178.1K |
Showing 1–10 of 116
Other providers in the same ZIP code as Propath Services, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Epic Health Services, Inc. | TX | Home Health Agency | $0 | $75M |
| Lala Healthcare Solutions LLC | TX | Home Health Agency | $0 | $40.8M |
| Real Time Transport | TX | Secured Medical Transport (VAN) | $0 | $14M |
| Quantum Formula Diagnostics, LLC | TX | Clinical Medical Laboratory | $411K | $4.3K |
| Amanda Smith | TX | Clinical Psychologist | $138K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.